Gerresheimer AG (WBO:GXI) ROCE % : 5.43% (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Gerresheimer AG ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Gerresheimer AG's annualized ROCE % for the quarter that ended in Feb. 2024 was 5.43%.

Gerresheimer AG ROCE % Historical Data

The historical data trend for Gerresheimer AG's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG ROCE % Chart

Gerresheimer AG Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

ROCE %

Get a 7-Day Free Trial

6.62

8.23

7.37

7.95

9.22

Gerresheimer AG Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
ROCE %	Get a 7-Day Free Trial															5.59	9.86	8.45	11.08	5.43

Gerresheimer AG ROCE % Calculation

Gerresheimer AG's annualized ROCE % for the fiscal year that ended in Nov. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Nov. 2023 )		(A: Nov. 2022 )		(A: Nov. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Nov. 2023 )		(A: Nov. 2022 )		(A: Nov. 2023 )
	=	217.864	/	( ( (3354.293 - 1101.431)	+	(3429.139 - 957.966) )	/ 2 )
	=	217.864	/	( (2252.862	+	2471.173)	/ 2 )
	=	217.864	/	2362.0175
	=	9.22 %

Gerresheimer AG's ROCE % of for the quarter that ended in Feb. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Feb. 2024 )		(Q: Nov. 2023 )		(Q: Feb. 2024 )
	=	134.964	/	( ( (3429.139 - 957.966)	+	(3469.201 - 973.199) )	/ 2 )
	=	134.964	/	( ( 2471.173	+	2496.002 )	/ 2 )
	=	134.964	/	2483.5875
	=	5.43 %

(1) Note: The EBIT data used here is four times the quarterly (Feb. 2024) EBIT data.

Gerresheimer AG (WBO:GXI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Gerresheimer AG ROCE % Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gerresheimer AG (WBO:GXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (WBO:GXI) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

GXId:UK 0NTI:UK GXI:Germany

Address

Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468

Website

https://www.gerresheimer.com

Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG (WBO:GXI) Headlines

No Headlines